Chris Carpenter
InvestorExecutive Partner, Private Equity at Sofinnova Ventures
Cambridge, Massachusetts, United States
Find your path to Chris
268 people in our graph share verified history with Chris — schools, employers, funds. One of them is your warm intro.
About
Chris Carpenter is an oncology physician-scientist with over two decades of clinical and laboratory experience who joined Sofinnova in 2022, focusing on clinical-stage product companies in oncology, rare diseases, and specialty therapeutics. He previously served as Chief Medical Officer at CatamaranBio and Rubius Therapeutics, and led cancer epigenetics at GlaxoSmithKline as well as drug development work at Merck. He holds a B.S. from Stanford University and M.D. and Ph.D. degrees from the University of Southern California, and is board certified in internal medicine and medical oncology.
Contact· self-published, not guessed
Invests in
Biotech
Experience
- Sofinnova InvestmentsExecutive Partnercurrent2022 — presentBoston, Massachusetts, United States
- Catamaran BioChief Medical Officer2020 — 2022Cambridge, Massachusetts, United States
- Self-employedConsultant2020 — 2022
- Rubius TherapeuticsChief Medical Officer2017 — 2020Cambridge, MA
- GSKVP/SVP, Cancer Epigenetics DPU Head2013 — 2017
- GSKProject Physician Leader2011 — 2013Greater Philadelphia
- MerckDirector, Clinical Oncology2007 — 2011
- Harvard Medical SchoolAssistant/Associate Professor of Medicine1996 — 2007
Skills & more
From Chris's professional profile.
Deals · 1
Atsena Therapeutics, Inc.Board seat
via Sofinnova Ventures · filed Apr 2025 · $150M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
AlkeusAtsenaCapstan
Sources: the firm's website · SEC Form D filings.
Colleagues at Sofinnova Ventures
Frequently asked questions
- Who is Chris Carpenter?
- Chris Carpenter is an oncology physician-scientist with over two decades of clinical and laboratory experience who joined Sofinnova in 2022, focusing on clinical-stage product companies in oncology, rare diseases, and specialty therapeutics. He previously served as Chief Medical Officer at CatamaranBio and Rubius Therapeutics, and led cancer epigenetics at GlaxoSmithKline as well as drug development work at Merck. He holds a B.S. from Stanford University and M.D. and Ph.D. degrees from the University of Southern California, and is board certified in internal medicine and medical oncology.
- Where does Chris Carpenter work?
- Chris Carpenter is Executive Partner, Private Equity at Sofinnova Ventures.
- What does Chris Carpenter invest in?
- Chris Carpenter invests in Biotech.
- What boards does Chris Carpenter sit on?
- Chris Carpenter holds tracked board seats at Alkeus, Atsena, Atsena Therapeutics, Inc., Capstan.
- Where did Chris Carpenter go to school?
- Chris Carpenter studied at Stanford University (Bachelor of Science (BS), Biology, General); University of Southern California (Doctor of Medicine (MD) Doctor of Philosophy (PhD), Pharmacology).
Same school
Also attended Stanford University2,000
+ 1,994 more
Also attended University of Southern California958
+ 952 more
Shared employers
Also worked at Catamaran Bio4
Also worked at Rubius Therapeutics6
Also worked at GSK275
+ 269 more
Also worked at Merck261
+ 255 more